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ABSTRACT
Objective: The purpose of this study of sickle cell disease (SCD) was to determine whether arterio-
pathy, measurable as intracranial vessel signal loss on magnetic resonance angiography (MRA),
was associated with low nocturnal hemoglobin oxygen saturation (SpO2) or hemolytic rate, mea-
surable as reticulocytosis or unconjugated hyperbilirubinemia.
Methods: Ninety-five East London children with SCDwithout prior stroke had overnight pulse oxi-
metry, of whom 47 (26 boys, 39 hemoglobin SS; mean age 9.1 6 3.1 years) also had MRA,
transcranial Doppler (TCD), steady-state hemoglobin, and reticulocytes within 34 months. Two
radiologists blinded to the other data graded arteriopathy on MRA as 0 (none) or as increasing
severity grades 1, 2, or 3.
Results: Grades 2 or 3 arteriopathy (n5 24; 2 with abnormal TCD) predicted stroke/TIA compared
with grades 0 and 1 (log-rank x2 [1, n 5 47] 5 8.1, p 5 0.004). Mean overnight SpO2 correlated
negatively with reticulocyte percentage (r 5 20.387; p 5 0.007). Despite no significant differ-
ences across the degrees of arteriopathy in genotype, mean overnight SpO2 was higher (p ,
0.01) in those with grade 0 (97.0% 6 1.6%) than those with grades 2 (93.9 6 3.7%) or 3
(93.5% 6 3.0%) arteriopathy. Unconjugated bilirubin was not associated but reticulocyte per-
centage was lower (p, 0.001) in those with grade 0 than those with grades 2 and 3 arteriopathy.
In multivariable logistic regression, lower mean overnight SpO2 (odds ratio 0.50, 95%confidence
interval 0.26–0.96; p , 0.01) predicted arteriopathy independent of reticulocyte percentage
(odds ratio 1.47, 95% confidence interval 1.15–1.87; p 5 0.003).
Conclusion: Low nocturnal SpO2 and reticulocytosis are associated with intracranial arteriopathy
in children with SCD. Preventative strategies might reduce stroke risk. Neurology® 2017;89:1–7
GLOSSARY
ANOVA5 analysis of variance; ICA5 internal carotid artery; IQR5 interquartile range;MCA5middle cerebral artery;MR5
magnetic resonance; MRA 5 magnetic resonance angiography; NOD 5 nocturnal oxygen desaturation; OSA 5 obstructive
sleep apnea; SCD 5 sickle cell disease; STOP 5 Stroke Prevention Trial in Sickle Cell Anemia; TCD 5 transcranial Doppler;
TE 5 echo time; TR 5 repetition time..
Patients with sickle cell disease (SCD) and stroke typically have stenosis or occlusion of the ar-
teries of the Circle of Willis1 detectable with magnetic resonance angiography (MRA).2 Cerebral
artery vessel turbulence or signal loss on MRA is associated with perfusion abnormality.3 There
are few MRA data in unselected asymptomatic patients with SCD and risk factors for MRA
abnormality remain unclear.4,5
Sleep-disordered breathing is a risk factor for stroke6 and carotid artery intima-media thick-
ness, wall diameter, and plaque formation in adults7,8; the strongest association is with low
hemoglobin oxygen saturation (SpO2).9,10 Episodic nocturnal oxygen desaturation (NOD) is
common in children with SCD,11 in part related to upper airway obstruction secondary to
adenotonsillar hypertrophy. Continuous NOD affects up to 40% of children with SCD12 and
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may persist during the day.13 Increased inflam-
mation is associated with both episodic and
continuous NOD in SCD.13,14 CNS events,
including stroke, in untreated patients have
been associated with obstructive sleep apnea
(OSA)15 and lower prestroke daytime and noc-
turnal SpO2.16,17 Maximum internal carotid
artery (ICA)/middle cerebral artery (MCA)
velocities on transcranial Doppler (TCD) are
associated with daytime SpO2 independently
of haemoglobin.18,19 In this secondary analysis
of cross-sectional data from the East London
cohort, we hypothesized that the severity of
NOD would be associated with the degree
of arteriopathy, measured as turbulence17 or
signal loss in the intracranial vessels on
MRA. Cerebrovascular disease may be associ-
ated with hemolysis,20,21 so we included
steady-state reticulocyte count and unconju-
gated bilirubin in the statistical models. The
data have been published in abstract form.22
METHODS Patients. From January 1, 1991, until December
31, 1993, all children without previous stroke regularly attending
the hemoglobinopathy clinic of Queen ElizabethHospital, Hackney,
were invited to participate in a prospective study designed to
examine whether abnormal TCD and overnight pulse oximetry
studies predicted CNS events. Asymptomatic children over the
age of 7 years were invited to undergo MRI and MRA without
sedation. All MRA scans were undertaken in asymptomatic
children and as this cohort was recruited before the results of
the Stroke Prevention Trial in Sickle Cell Anemia (STOP) trial
were available,23 children with abnormal TCD were not trans-
fused. Children were followed until they had a recurrent stroke
or TIA or, if they did not, until April 30, 2000.
Standard protocol approvals, registrations, and patient
consents. Approval was granted by the local National Health
Service Research Ethics Committee and written informed con-
sent was obtained from the parents of all participants.
Overnight sleep studies. Overnight studies were performed
using a Biox 3700 pulse oximeter (Datex-Ohmeda; Hatfield,
Hertfordshire, UK) to record SpO2 during sleep in 63 patients
at home and, in the rest of the study population, in the hospital
sleep laboratory.17 The results were analyzed before the MRI data
were available. We recorded the mean and minimum SpO2 and
the proportion of sleep spent at SpO2 less than 90% and less than
80%, and examined the trace for dips (.4% from baseline) in
oxygenation associated with acute pulse rate rises. Patients with
symptoms of OSA were referred for consideration of
adenotonsillectomy.
Transcranial Doppler studies. Transcranial Doppler was
undertaken routinely in clinic and was classified as standard risk,
conditional, or abnormal (maximum ICA/MCA velocity ,170
cm/s, 170–199 cm/s, or $200 cm/s, respectively).24
Magnetic resonance studies. Magnetic resonance (MR) stud-
ies were performed on a 1.5T S Vision whole body imaging sys-
tem (Siemens AG; Erlangen, Germany).3
Structural MRI. The structural MRI investigation included
sagittal and coronal T1-weighted images (repetition time [TR]
570 ms, echo time [TE] 14 ms), axial turbo spin echo T2-
weighted images (TR 3,458 ms, TE 96 ms), and coronal turbo
fluid-attenuated inversion recovery T2-weighted images (TR
9,999 ms, TE 119 ms, inversion time 2,210 ms).
MR angiography. MRA was performed using a 3D time-of-
flight method, acquiring 3 slabs, each of 3.2 mm thickness,
centered on the circle of Willis (TR 35 ms, TE 7.2 ms, flip angle
208). Interobserver variability was compared without discussion
by 2 neuroradiologists (M.B. and D.E.S.) in a set of MRAs
examined carefully for evidence of arteriopathy, demonstrable as
turbulence or signal loss, particularly in the terminal ICA and in
the A1, M1, M2, P1, and P2 segments of the basal vessels. Ar-
teriopathy on MRA was graded according to severity of signal loss
(0, none; 1, minor signal attenuation; 2, obvious signal attenu-
ation, but presence of distal flow; 3, signal loss and no distal flow;
figure) and the worst arteriopathy in any vessel was recorded. In
addition, moyamoya collaterals were also noted. For the full
cohort, MRAs were reviewed by M.B. and T.C.C. and grading
agreed after discussion, but blind to the oximetry data.
Laboratory investigations. Laboratory data were available
from a cross-sectional study of patients in steady state, i.e., clin-
ically well with no pain or other complications, undertaken in
1994.25
Statistical analysis. All variables were examined for normality
(Shapiro-Wilk) and for those that were not normally distributed,
nonparametric descriptives and statistical tests were selected
where required. Using Kappa statistics, reproducibility for any
degree of arteriopathy was documented in those patients who
had repeat MRA within 3 years or at any time rated by T.C.C.,
M.B., or D.E.S. and interobserver variability was compared in
a set of MRAs rated byM.B. and D.E.S. without discussion. Pres-
ence of arteriopathy on MRA was compared with TCD categories
using x2. Between MRA groups, continuous variables were com-
pared using analysis of variance (ANOVA) or Kruskal-Wallis one-
way ANOVA, as appropriate. Kaplan-Meier survival curves and
the log-rank test were used to compare TCD or MRA arterio-
pathy as a predictor of ischemic stroke or TIA. Logistic regression
analysis was used to determine the independent contributions of
variables to the prediction of normal and mild vs moderate or
severe arteriopathy on MRA. Only variables that differed between
arteriopathy groups at the univariate level were entered into the
multivariable regression model. We assumed statistical signifi-
cance at p , 0.05 but present confidence intervals to clarify the
exact strength of statistical relationships. Analysis was conducted
using SPSS (release 20.0) (SPSS Inc., Chicago, IL).
RESULTS Patient characteristics. Data were collected
prospectively in 147 children seen before April
2001 for TCD screening, of whom 95 had an over-
night pulse oximetry study lasting 4.3–8.2 (median
7.5) hours.17 3D time-of-flight MRA data3 were
available for 56 of these children a median of 0.5
(interquartile range [IQR] 17.3) months from the
sleep study. Forty-eight had HbSS, 4 had HbSb0
thalassemia, and 4 had HbSC disease; 30 (54%) were
boys and median age at the time of MR scanning was
9 (IQR 5) years. Forty-seven children (26 boys, 39
with HbSS, 4 with HbSb0 thalassemia, and 4 with
HbSC disease; mean age 9.1 6 3.1 years) had
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overnight oximetry studies within 3 years of their
MRA and form the cohort for this analysis. Four had
a stroke and 6 a TIA at a median of 4.12 (range 1.40–
6.03) years after MRA.
Validation of the arteriopathy scale. Kappa was 0.90 for
masked rating of the index MRA using the arteriopa-
thy scale in 14 patients, i.e., excellent interobserver reli-
ability. MRA was repeated at a median of 3.16 (range
0.26–9.38) years in 31 of the children; kappa for com-
parison of presence of arteriopathy at the 2 time points
was 0.36 (fair agreement) but kappa was 1.0 (excellent
agreement) for comparison of presence of arteriopathy
in the 11 who had a second MRA within 3 years.
Arteriopathy on MRA and TCD and prediction of stroke
or TIA or silent infarction. Seventeen children had nor-
mal MRA, while 6, 11, and 13 had grades 1, 2, and 3
arteriopathy, respectively. None had moyamoya collat-
erals. The 2 children with abnormal TCD and 1 of the
2 with conditional TCD at baseline had severe arterio-
pathy onMRA, while the other with conditional TCD
at baseline had moderate arteriopathy. The 2 with
abnormal TCD both had an ischemic stroke subse-
quently, as did 2 with normal TCD; although none
of the 7 children with conditional TCD at any time
had a stroke, one had a TIA. Despite the small number
of events in this subset,17 survival analysis showed that
abnormal TCD at baseline predicted stroke or TIA in
the full dataset (log rank x2 [1, n 5 47] 6.369; p 5
0.012) or including only patients with HbSS (log rank
x2 [1, n 5 39] 5 4.845, p 5 0.028).
All 4 of those who had a stroke at follow-up had
moderate or severe arteriopathy on MRA at baseline,
as did 5 of 6 of those who had a subsequent TIA.
Grade of arteriopathy on MRA predicted stroke or
TIA in the full dataset (log rank x2 [3, n 5 47] 5
12.352, p 5 0.006) or including only patients with
HbSS (log rank x2 [3, n5 39]5 8.233, p5 0.041).
Two children had new silent infarction on follow-
up MRI, 1 with grade 0 and the other with grade 1
MRA; both had standard risk TCD.
Associations with arteriopathy on MRA. There was no
difference in the distribution of arteriopathy rankings
for male and female participants (x2 [3, n 5 47] 5
4.55, p5 0.208) (in arteriopathy categories 0, 1, 2, 3,
there were 11/17, 5/6, 4/11, and 6/13 male partic-
ipants, respectively), or in the distribution of age
across the arteriopathy groups (F , 1). One child
with HbSb0 thalassemia had grade 2 arteriopathy
while the other 7 with compound genotypes had nor-
mal MRA and the remaining 29 with arteriopathy
had HbSS (x2 [6, n 5 47] 5 12.26, p 5 0.056).
There were no differences across the different
degrees of arteriopathy in unconjugated bilirubin
(F3,405 0.127, p5 0.944) or aspartate transaminase
(F3,40 5 0.068, p 5 0.977). There were, however,
differences in hemoglobin (F3,46 5 3.646, p 5 0.02)
and in reticulocyte percentage (F3,46 5 12.281, p ,
0.001). Post hoc analysis revealed lower hemoglobin
in grade 3 arteriopathy compared with patients with
no vascular disease (mean difference 21.78, p 5
0.017), and lower mean reticulocyte percentage in
patients with no vascular disease compared with those
with grade 2 and grade 3 arteriopathy (mean differ-
ences, 27.57, p 5 0.001, and 210.42, p , 0.001,
respectively) (table 1).
Figure Arteriopathy on magnetic resonance angiography (MRA) in sickle cell disease
Arteriopathy on MRA graded as 0, none (A); 1, minor signal attenuation (B); 2, obvious signal attenuation, but presence of
distal flow (C); 3, signal loss (D).
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There was also a difference in mean overnight
SpO2 for those with different degrees of arterio-
pathy (F3,46 5 5.11, p 5 0.004). Post hoc analysis
revealed higher mean overnight SpO2 in patients
with no vascular disease compared with those with
grades 2 and 3 arteriopathy (mean difference
3.08%, p 5 0.024, 3.50%, p 5 0.005, respec-
tively) (table 1). Repeating this analysis for
those with HbSS alone did not change this result
(F3,35 5 3.77, p 5 0.02); mean difference in mean
overnight SpO2 in patients with no vascular disease
compared with those with grade 2 and 3 arterio-
pathy was 3.49% and 3.52%, respectively (p 5
0.046 and 0.028, respectively).
Reticulocyte percentage was higher in those
with lower overnight mean oxyhemoglobin satura-
tion (r[47]520.387, p5 0.007). Given the com-
bined reticulocyte and oximetry findings, in 2
separate models, the children were recategorized
into 2 arteriopathy groups contrasting (1) no with
mild, moderate, or severe arteriopathy and (2) no
or mild arteriopathy with moderate or severe arte-
riopathy for the logistic regression (tables 2 and 3).
As there were no differences in the variables signif-
icantly associated with arteriopathy in the univari-
able analysis, multivariable logistic regression was
undertaken comparing no with mild, moderate, or
severe arteriopathy.
Logistic analysis was conducted retrospectively
to examine the effect of mean overnight hemoglo-
bin saturation (step 1) and reticulocyte percentage
(step 2) on no (grade 0; n 5 17) vs mild, moderate,
or severe (grades 1, 2, or 3; n 5 30) arteriopathy.
Mean overnight hemoglobin oxygen saturation
predicted arteriopathy category (x2 [1, n1 5 17,
n2 5 30] 5 15.93, p , 0.001, R2 5 0.29,
68.1% correct classification). When reticulocyte
percentages were added (step 2), the explanatory
power of the model increased (x2 [1, n1 5 17,
n2 5 30] 5 18.09, p , 0.001, R2 5 0.52,
80.9% correct classification). As can be seen from
the summary in table 2, lower mean overnight









Age, y 10.3 6 3.0 10.0 6 4.2 8.6 6 3.0 9.2 6 2.6
Hemoglobina 9.5 6 1.8 9.3 6 1.4 8.6 6 1.2 7.7 6 1.4b
White cell count 11.1 6 4.7 12.5 6 5.5 14.2 6 5.8 12.2 6 3.0
Reticulocyte %c 6.29 6 4.12 11.92 6 4.43 13.86 6 3.95b 16.72 6 6.43b
Unconjugated bilirubin 41.1 6 27.5 35.5 6 20.9 42.0 6 20.0 41.3 6 15.6
Aspartate transaminase 74.1 6 25.8 77.2 6 16.9 75.5 6 15.2 72.7 6 21.3
Values are mean 6 SD.
ap , 0.05.
bSignificantly different from those with no arteriopathy on post hoc testing.
cp , 0.01.
Table 2 Univariable logistic regression analysis for variables predicting no arteriopathy on magnetic resonance angiography (MRA) vs mild,
moderate, or severe arteriopathy or no or mild arteriopathy on MRA vs moderate or severe arteriopathy (n 5 47)
Variable























Age 0.88 (0.72–1.08) 0.2 0.864 (0.756–1.058) 0.2
Mean SpO2 0.51 (0.32–0.81) 0.004 0.645 (0.472–0.882) 0.006
Hemoglobin 0.64 (0.43–0.95) 0.03 0.551 (0.352–0.868) 0.01
White cell count 1.10 (0.96–1.27) 0.2 1.084 (0.952–1.235) 0.2
Reticulocyte % 1.54 (1.20–1.96) 0.001 1.355 (1.141–1.601) 0.001
Unconjugated
bilirubin
0.998 (0.968–1.027) 0.9 1.005 (0.976–1.035) 0.7
Aspartate
transaminase
1.001 (0.971–1.032) 0.9 0.997 (0.968–1.027) 0.9
Abbreviation: CI 5 confidence interval.
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hemoglobin oxygen saturation and higher reticulo-
cyte percentage were both independent predictors
of mild to severe MRA arteriopathy.
DISCUSSION There are few data on the relationship
among hemoglobin oxygen saturation, markers of
hemolysis, and vascular abnormality in SCA.5,20
Our data demonstrate that, in unselected initially
asymptomatic children with SCD, higher reticulocyte
percentage and overnight hemoglobin oxygen satura-
tion are independently associated with the degree of
arteriopathy on MRA. The lack of association with
unconjugated bilirubin and aspartate transaminase
means that it is possible that the association with
reticulocytosis may represent erythropoiesis in
response to hypoxic exposure rather than hemolytic
rate.
Possible mechanisms underlying daytime and noc-
turnal hemoglobin oxygen desaturation include OSA,
chronic lung disease, right-to-left shunting at atrial or
pulmonary level with pulmonary hypertension, and
abnormality in hemoglobin oxygen affinity.21 Our
data suggest that the intracranial vessel abnormalities
in SCD are also related to low hemoglobin oxygen
saturation directly, as well as via a correlation with
reticulocytosis. There is some evidence for a link
between hypoxia and processes that might lead to
nonatherosclerotic vasculopathy, including vasocon-
striction,26 medial necrosis,27 and intimal
hyperplasia.28
The correlation between reticulocyte percentage
and degree of desaturation and the independent
effects of reticulocytosis and nocturnal hemoglobin
oxygen desaturation on the severity of MRA
arteriopathy in our data is intriguing. Reticulocyte
percentage is an independent predictor of cerebro-
vascular disease in children with SCD.29,30 Inter-
ventions that improve hemoglobin oxygen
saturation and reduce the reticulocytosis in sickle
cell disease (e.g., transfusions, hydroxycarbamide)
may decrease many of the observed vaso-occlusive
phenomena.
In our data, the main association with the degree
of arteriopathy in the MCAs was low baseline hemo-
globin oxygen saturation and there was no association
with dips in hemoglobin oxygen saturation or
the minimum hemoglobin oxygen saturation. Ane-
mia was also associated with the degree of arteriopa-
thy on MRA, but not as strongly as the hemoglobin
oxygen saturation. Interestingly, although there is evi-
dence that chronic inflammation may be associated
with the severity of vasculopathy, the white count
at the time of the study was not associated with the
degree of arteriopathy on MRA in our data. A larger
dataset, perhaps incorporating measures of inflamma-
tion from earlier in childhood, might be instructive,
as MRA abnormality is probably the end stage of
a protracted and complex process.
Constriction, stenosis, and occlusion in vessels
may be seen as flow-induced signal attenuation on
time-of-flight MRA, which we have categorized as
degree of signal loss as the structure of the vessel wall
is not imaged. It is rarely justifiable to obtain conven-
tional arteriography and pathologic data are likely to
remain scarce, but arteriopathy may be documented
even in very young children using TCD, allowing
study of the effects of exposure to hemoglobin oxygen
desaturation and any interaction with hemolysis.
Nocturnal hemoglobin oxygen desaturation as
a result of OSA is common in childhood. However,
in the absence of SCD, cardiac disease, or an intercur-
rent illness, arterial ischemic stroke in this group is
rare. It is possible that the common link between
the pathophysiologic mechanisms of stroke in adult-
hood and childhood and nocturnal hemoglobin oxy-
gen desaturation is that the first hit of damaged
arterial endothelium, perhaps as a result of infection
or mechanical and cellular factors in SCD, is followed
by the second hit of nocturnal hemoglobin oxygen
desaturation with or without sleep-disordered breath-
ing, resulting in medial necrosis or a vicious cycle of
intimal hyperplasia and leading to steno-occlusion,
which increases the risk of stroke.
We found that the children with abnormal TCD
had severe arteriopathy on MRA, in contrast to only
25% of those studied as part of the STOP trial,31 and
MRA abnormality was also documented in a number
of children with standard risk TCD. It might be
argued that the long TR used in this study meant
that MRA abnormality was overreported but the
interobserver reliability and reproducibility for studies
repeated in the short and medium terms were excel-
lent. We have previously shown a relationship
between MRA abnormality and focal perfusion defi-
cits3 and MRA abnormality predicted all the subse-
quent strokes and all but one of the TIAs, suggesting
that the arteriopathy detected was clinically signifi-
cant. The main weakness is that this was a secondary
Table 3 Summary of logistic regression analysis for variables predicting no
arteriopathy on magnetic resonance angiography vs mild, moderate, or
severe arteriopathy (n 5 47)
Variable B SE B Odds ratio 95% Confidence intervals
Step 1
Mean overnight SpO2 20.67a 0.24 0.51 0.32–0.81
Step 2
Mean overnight SpO2 20.69b 0.33 0.50 0.26–0.96
Reticulocyte percentage 0.38a 0.13 1.47 1.14–1.89
ap , 0.01.
bp , 0.05.
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analysis of data collected for 3 cross-sectional studies
undertaken in asymptomatic children with SCD
within 3 years. Prospective studies might look at the
relationship among MRA arteriopathy, polysomnog-
raphy, and hematology undertaken on the same day
to further document the pathophysiology of cerebro-
vascular disease in SCD.
Early correction of hemoglobin oxygen desatura-
tion, for example with hydroxyurea,32 adenotonsillec-
tomy,33 or auto-adjusting continuous positive airway
pressure,34 may reduce the risk of CNS events in
children. Strategies, justifiable and feasible in young
children, to improve hemoglobin oxygen saturation
should be explored with the goal of preventing or
reversing the vasculopathy and reducing the risk of
stroke in this population.
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